Cargando…
Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles
Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease, is known to increase the risk of colitis-associated cancer (CAC). CAC has been found to be unresponsive to standard chemotherapy regimens, and the current treatments do not utilize effective small-molecule...
Autores principales: | Long, Dingpei, Alghoul, Zahra, Sung, Junsik, Yang, Chunhua, Merlin, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534593/ https://www.ncbi.nlm.nih.gov/pubmed/37765299 http://dx.doi.org/10.3390/pharmaceutics15092331 |
Ejemplares similares
-
Orally Administered Natural Lipid Nanoparticle-Loaded 6-Shogaol Shapes the Anti-Inflammatory Microbiota and Metabolome
por: Yang, Chunhua, et al.
Publicado: (2021) -
Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate
por: Yang, Chunhua, et al.
Publicado: (2022) -
Preparation and Characterization of IL-22 mRNA-loaded Lipid Nanoparticles
por: Alghoul, Zahra, et al.
Publicado: (2023) -
The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
por: Alghoul, Zahra, et al.
Publicado: (2022) -
Impact of PepT1 deletion on microbiota composition and colitis requires multiple generations
por: Viennois, Emilie, et al.
Publicado: (2020)